AIDS

Handbook developed by the DC DOH provides guidance on how to advise patients on the benefits of PrEP.

This report summarizes the critical role urbanization practices play in large cities and how they can be used to end the AIDS epidemic by 2030.

AIDSVu offers a variety of ready-made materials and data sets to help illustrate the impact of HIV in the United States. This report presents the state of HIV/AIDS in the United States using 2012 data.

This Vital Signs highlights the importance of expanding access to SSPs, which provide sterile needles and syringes and ideally offer many other comprehensive services to help improve the health of PWID and their communities, such as treatment for substance use disorder, HIV, and hepatitis testing and linkage to treatment, and safe disposal of used syringes.

This guideline provides comprehensive, evidence-based recommendations on prophylaxis, treatment, immunization, and drug interactions for a wide range of pediatric OIs—including new additions for coccidioidomycosis, hepatitis B revaccination, and updated immunization schedules—to guide clinicians caring for HIV‑exposed and infected children.

This guideline offers updated, evidence-based recommendations—from preconception through postpartum—on universal prenatal HIV testing, preferred antiretroviral regimens (e.g., bictegravir/TAF/FTC), maternal viral monitoring, obstetric management, and neonatal prophylaxis to further reduce perinatal HIV transmission toward elimination goals (defined as <1% transmission rate and <1 infection per 100,000 live births).

This information sheet offers an in-depth analysis of current AFP models—including funding mechanisms, stakeholder roles, and implementation strategies—to support sustainability of HIV-related services beyond traditional grant funding. It outlines key considerations and best practices to help health departments and community partners explore and launch innovative financing options for long-term epidemic response planning.

This toolkit supports Ryan White HIV/AIDS Program (RWHAP) Part B AIDS Drug Assistance Programs (ADAPs)—which provide access to HIV-related medications for low-income individuals—in navigating the planning, selection, and implementation of benefits management contracts. It offers key definitions, planning tools, real-world examples, and checklists to help ADAP administrators—new or experienced—align contractor selection with their program’s unique infrastructure and needs.

In this webinar, CDC and HRSA speakers review the calendar year 2027–2031 Integrated HIV Prevention & Care Plan Guidance—highlighting key updates, submission requirements, and real-world recipient examples. The training equips CDC- and HRSA-funded jurisdictions with technical support, planning tools, and strategies to develop coordinated HIV prevention and care efforts by the June 30, 2026 deadline.